The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 05, 2021
Filed:
Aug. 28, 2014
Applicant:
Koninklijke Nederlandse Akademie Van Wetenschappen, Utrecht, NL;
Inventors:
Niels Geijsen, Utrecht, NL;
Diego Sebastián D'Astolfo, Utrecht, NL;
Assignee:
Koninklijke Nederlandse Akademie van Wetenschappen, Utrecht, NL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 47/02 (2006.01); A61K 47/20 (2006.01); A61K 47/12 (2006.01); A61K 47/10 (2017.01); C12N 15/86 (2006.01); A61K 35/545 (2015.01); C12N 15/87 (2006.01); A61K 35/30 (2015.01); A61K 38/17 (2006.01); A61K 38/45 (2006.01); A61K 38/46 (2006.01); A61K 47/18 (2017.01); A61K 47/22 (2006.01); C07K 14/32 (2006.01); C07K 14/47 (2006.01); C12N 7/00 (2006.01); C12N 9/12 (2006.01); C12N 9/16 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 35/30 (2013.01); A61K 35/545 (2013.01); A61K 38/1709 (2013.01); A61K 38/45 (2013.01); A61K 38/465 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/18 (2013.01); A61K 47/20 (2013.01); A61K 47/22 (2013.01); C07K 14/32 (2013.01); C07K 14/4702 (2013.01); C12N 7/00 (2013.01); C12N 9/1241 (2013.01); C12N 9/16 (2013.01); C12N 15/87 (2013.01); C07K 2319/21 (2013.01); C07K 2319/50 (2013.01); C07K 2319/55 (2013.01); C12N 2740/15043 (2013.01); C12Y 207/07 (2013.01); C12Y 301/00 (2013.01);
Abstract
The invention relates to transduction compounds, buffers and methods for introducing molecules into cells. The invention also relates to methods of treatment, pharmaceutical compositions and other uses of the transduction compounds and buffers. The invention also relates to modified cells obtainable by the transduction compounds, buffers and methods of the invention.